In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Alnylam Pharmaceuticals Inc’s stock clocked out at $289.00, down -1.22% from its previous closing price of $292.58. In other words, the price has decreased by -$1.22 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
To gain a deeper understanding of ALNY’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.98 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 23.58 whereas as Long-Term Debt/Eq ratio is at 22.47.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on March 31, 2025, initiated with a Buy rating and assigned the stock a target price of $353.
On March 24, 2025, JP Morgan Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $280 to $328.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when BONNEY MICHAEL W sold 11,250 shares for $277.71 per share. The transaction valued at 3,124,217 led to the insider holds 16,804 shares of the business.
BONNEY MICHAEL W bought 11,250 shares of ALNY for $3,032,212 on May 15 ’25. On Aug 29 ’24, another insider, Reitan Colleen F, who serves as the Director of the company, bought 32 shares for $286.00 each. As a result, the insider paid 9,152 and bolstered with 32 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 16.05 while its Price-to-Book (P/B) ratio in mrq is 326.24.
Stock Price History:
Over the past 52 weeks, ALNY has reached a high of $304.39, while it has fallen to a 52-week low of $146.79. The 50-Day Moving Average of the stock is 11.96%, while the 200-Day Moving Average is calculated to be 10.72%.
Shares Statistics:
A total of 130.31M shares are outstanding, with a floating share count of 124.67M. Insiders hold about 4.39% of the company’s shares, while institutions hold 96.25% stake in the company.
